| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 1069 | 2017 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 906 | 2018 |
| ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity JA Moral, J Leung, LA Rojas, J Ruan, J Zhao, Z Sethna, A Ramnarain, ... Nature 579 (7797), 130-135, 2020 | 306 | 2020 |
| Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms MA Lowery, W Wong, EJ Jordan, JW Lee, Y Kemel, J Vijai, D Mandelker, ... JNCI: Journal of the National Cancer Institute 110 (10), 1067-1074, 2018 | 223 | 2018 |
| Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype MA Lowery, EJ Jordan, O Basturk, RN Ptashkin, A Zehir, MF Berger, ... Clinical Cancer Research 23 (20), 6094-6100, 2017 | 191 | 2017 |
| Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency VWK Silva, G Askan, TD Daniel, M Lowery, DS Klimstra, GK Abou-Alfa, ... Chinese clinical oncology 5 (5), 62-62, 2016 | 168 | 2016 |
| Ordered and deterministic cancer genome evolution after p53 loss T Baslan, JP Morris IV, Z Zhao, J Reyes, YJ Ho, KM Tsanov, J Bermeo, ... Nature 608 (7924), 795-802, 2022 | 164 | 2022 |
| Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer LF Escobar-Hoyos, A Penson, R Kannan, H Cho, CH Pan, RK Singh, ... Cancer cell 38 (2), 198-211. e8, 2020 | 150 | 2020 |
| Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity? IH Sahin, G Askan, ZI Hu, EM O’Reilly Annals of Oncology 28 (12), 2950-2961, 2017 | 121 | 2017 |
| DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma M Vyas, JF Hechtman, Y Zhang, R Benayed, A Yavas, G Askan, J Shia, ... Modern Pathology 33 (4), 648-656, 2020 | 116 | 2020 |
| The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes O Basturk, M Tan, U Bhanot, P Allen, V Adsay, SN Scott, R Shah, ... Modern Pathology 29 (9), 1058-1069, 2016 | 106 | 2016 |
| PanIN neuroendocrine cells promote tumorigenesis via neuronal cross-talk S Sinha, YY Fu, A Grimont, M Ketcham, K Lafaro, JA Saglimbeni, G Askan, ... Cancer research 77 (8), 1868-1879, 2017 | 100 | 2017 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018; 8: 1112–1129. doi: 10.1158/2159-8290 H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... CD-18-0349.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 93 | |
| Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases O Basturk, V Adsay, G Askan, D Dhall, G Zamboni, M Shimizu, K Cymes, ... The American journal of surgical pathology 41 (3), 313-325, 2017 | 89 | 2017 |
| Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas O Basturk, SM Chung, RH Hruban, NV Adsay, G Askan, ... Virchows Archiv 469, 523-532, 2016 | 84 | 2016 |
| Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma O Basturk, MF Berger, H Yamaguchi, V Adsay, G Askan, UK Bhanot, ... Modern Pathology 30 (12), 1760-1772, 2017 | 82 | 2017 |
| Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns CS Sigel, E Drill, Y Zhou, O Basturk, G Askan, LM Pak, E Vakiani, T Wang, ... The American journal of surgical pathology 42 (10), 1334-1345, 2018 | 61 | 2018 |
| Intraductal oncocytic papillary neoplasms: clinical-pathologic characterization of 24 cases, with an emphasis on associated invasive carcinomas T Wang, G Askan, V Adsay, P Allen, WR Jarnagin, B Memis, C Sigel, ... The American journal of surgical pathology 43 (5), 656-661, 2019 | 59 | 2019 |
| Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer J Zheng, JM Hernandez, A Doussot, L Bojmar, CP Zambirinis, ... Hpb 20 (7), 597-604, 2018 | 58 | 2018 |
| Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations RR Narayan, JM Creasy, DA Goldman, M Gönen, C Kandoth, R Kundra, ... Cancer 125 (4), 575-585, 2019 | 54 | 2019 |
Olca BasturkMemorial Sloan Kettering Cancer CenterZweryfikowany adres z mskcc.org
